Cognitive decline and quality of life in incident Parkinson's disease: The role of attention

Parkinsonism and Related Disorders

Volumn 27, Issue , 2016, Pages 47-53

  Lawson, Rachael A ^a   Yarnall, Alison J ^a   Duncan, Gordon W ^a,b   Breen, David P ^c   Khoo, Tien K ^d   Williams Gray, Caroline H ^c   Barker, Roger A ^c   Collerton, Daniel ^a   Taylor, John Paul ^a   Burn, David J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d GRIFFITH UNIVERSITY   (Australia)

Author keywords

Attention; Dementia; Mild cognitive impairment; Parkinson's disease; Quality of life

Indexed keywords

AGED; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DISEASE CLASSIFICATION; EXECUTIVE FUNCTION; FEMALE; GLOBAL COGNITION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; MONTREAL COGNITIVE ASSESSMENT; MOVEMENT DISORDER SOCIETY CRITERIA; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE 39; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; COGNITIVE DYSFUNCTION; FOLLOW UP; MIDDLE AGED; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATTENTION; COGNITIVE DYSFUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; QUALITY OF LIFE;

EID: 84963650298     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2016.04.009     Document Type: Article

References (30)

1. [1] Hely, M.A., Reid, W.G., Adena, M.A., Halliday, G.M., Morris, J.G., The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov. Disord. 23 (2008), 837–844.
2. [2] Leroi, I., McDonald, K., Pantula, H., Harbishettar, V., Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden. J. Geriatr. Psychiatry Neurol. 25 (2012), 208–214.
3. [3] Visser, M., Verbaan, D., van Rooden, S., Marinus, J., van Hilten, J., Stiggelbout, A., A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. Value Health 12 (2009), 392–396.
4. [4] Antonini, A., Barone, P., Marconi, R., Morgante, L., Zappulla, S., Pontieri, F., Ramat, S., Ceravolo, M., Meco, G., Cicarelli, G., Pederzoli, M., Manfredi, M., Ceravolo, R., Mucchiut, M., Volpe, G., Abbruzzese, G., Bottacchi, E., Bartolomei, L., Ciacci, G., Cannas, A., Randisi, M., Petrone, A., Baratti, M., Toni, V., Cossu, G., Dotto, P., Bentivoglio, A., Abrignani, M., Scala, R., Pennisi, F., Quatrale, R., Gaglio, R., Nicoletti, A., Perini, M., Avarello, T., Pisani, A., Scaglioni, A., Martinelli, P., Iemolo, F., Ferigo, L., Simone, P., Soliveri, P., Troianiello, B., Consoli, D., Mauro, A., Lopiano, L., Nastasi, G., Colosimo, C., The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. J. Neurol. 259 (2012), 2621–2631.
5. [5] Bronnick, K., Ehrt, U., Emre, M., De Deyn, P.P., Wesnes, K., Tekin, S., Aarsland, D., Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 77 (2006), 1136–1142.
6. [6] Hurt, C.S., Landau, S., Burn, D.J., Hindle, J.V., Samuel, M., Wilson, K., Brown, R.G., Cognition, coping, and outcome in Parkinson's disease. Int. Psychogeriatr. 24 (2012), 1656–1663.
7. [7] Yarnall, A.J., Breen, D.P., Duncan, G.W., Khoo, T.K., Coleman, S.Y., Firbank, M.J., Nombela, C., Winder-Rhodes, S., Evans, J.R., Rowe, J.B., Mollenhauer, B., Kruse, N., Hudson, G., Chinnery, P.F., O'Brien, J.T., Robbins, T.W., Wesnes, K., Brooks, D.J., Barker, R.A., Burn, D.J., Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD Study. Neurology 82 (2013), 308–316.
8. [8] Hughes, A.J., Daniel, S.E., Kilford, L., Lees, A.J., Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55 (1992), 181–184.
9. [9] Emre, M., Aarsland, D., Brown, R., Burn, D.J., Duyckaerts, C., Mizuno, Y., Broe, G.A., Cummings, J., Dickson, D.W., Gauthier, S., Goldman, J., Goetz, C., Korczyn, A., Lees, A., Levy, R., Litvan, I., McKeith, I., Olanow, W., Poewe, W., Quinn, N., Sampaio, C., Tolosa, E., Dubois, B., Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov. Disord. 22 (2007), 1689–1707.
10. [10] Goetz, C.G., Tilley, B.C., Shaftman, S.R., Stebbins, G.T., Fahn, S., Martinez-Martin, P., Poewe, W., Sampaio, C., Stern, M.B., Dodel, R., Dubois, B., Holloway, R., Jankovic, J., Kulisevsky, J., Lang, A.E., Lees, A., Leurgans, S., LeWitt, P.A., Nyenhuis, D., Olanow, C.W., Rascol, O., Schrag, A., Teresi, J.A., van Hilten, J.J., LaPelle, N., Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23 (2008), 2129–2170.
11. [11] Mathias, J.L., Bowden, S.C., Barrett-Woodbridge, M., Accuracy of the Wechsler test of Adult reading (WTAR) and national Adult reading test (NART) when estimating IQ in a healthy Australian sample. Aust. Psychol. 42 (2007), 49–56.
12. [12] Yesavage, J.A., Brink, T.L., Rose, T.L., Lum, O., Huang, V., Adey, M., Leirer, V.O., Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 17 (1982), 37–49.
13. [13] Tomlinson, C.L., Stowe, R., Patel, S., Rick, C., Gray, R., Clarke, C.E., Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov. Disord. 25 (2010), 2649–2653.
14. [14] Jenkinson, C., Fitzpatrick, R.A.Y., Peto, V.I.V., Greenhall, R., Hyman, N., The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 26 (1997), 353–357.
15. [15] Folstein, M.F., Folstein, S.E., McHugh, P.R., Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975), 189–198.
16. [16] Nasreddine, Z.S., Phillips, N.A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J.L., Chertkow, H., The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53 (2005), 695–699.
17. [17] Nicholl, C.G., Lynch, S., Kelly, C.A., White, L., Simpson, P.M., Wesnes, K.A., Pitt, B.M.N., The cognitive drug research computerized assessment system in the evaluation of early dementia-is speed of the essence?. Int. J. Geriatr. Psychiatry 10 (1995), 199–206.
18. [18] Robbins, T.W., James, M., Owen, A.M., Sahakian, B.J., McInnes, L., Rabbitt, P., Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 5 (1994), 266–281.
19. [19] Ala, T.A., Hughes, L.F., Kyrouac, G.A., Ghobrial, M.W., Elble, R.J., Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 70 (2001), 483–488.
20. [20] Litvan, I., Goldman, J.G., Tröster, A.I., Schmand, B.A., Weintraub, D., Petersen, R.C., Mollenhauer, B., Adler, C.H., Marder, K., Williams-Gray, C.H., Aarsland, D., Kulisevsky, J., Rodriguez-Oroz, M.C., Burn, D.J., Barker, R.A., Emre, M., Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement Disorder Society Task Force guidelines. Mov. Disord. 27 (2012), 349–356.
21. [21] Goldman, J.G., Holden, S., Bernard, B., Ouyang, B., Goetz, C.G., Stebbins, G.T., Defining optimal cutoff scores for cognitive impairment using movement disorder society task force criteria for mild cognitive impairment in Parkinson's disease. Mov. Disord. 28 (2013), 1972–1979.
22. [22] Clarke, C.E., Furmston, A., Morgan, E., Patel, S., Sackley, C., Walker, M., Bryan, S., Wheatley, K., Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson's disease: the PD OT trial. J. Neurol. Neurosurg. Psychiatry 80 (2009), 976–978.
23. [23] Klepac, N., Trkulja, V., Relja, M., Babic, T., Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study. Eur. J. Neurol. 15 (2008), 128–133.
24. [24] Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T.P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., Cicarelli, G., Gaglio, R.M., Giglia, R.M., Iemolo, F., Manfredi, M., Meco, G., Nicoletti, A., Pederzoli, M., Petrone, A., Pisani, A., Pontieri, F.E., Quatrale, R., Ramat, S., Scala, R., Volpe, G., Zappulla, S., Bentivoglio, A.R., Stocchi, F., Trianni, G., Dotto, P.D., The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov. Disord. 24 (2009), 1641–1649.
25. [25] Ballard, C.G., Aarsland, D., McKeith, I., O'Brien, J., Gray, A., Cormack, F., Burn, D., Cassidy, T., Starfeldt, R., Larsen, J.P., Brown, R., Tovee, M., Fluctuations in attention - PD dementia vs DLB with parkinsonism. Neurology 59 (2002), 1714–1720.
26. [26] Behari, M., Srivastava, A.K., Pandey, R.M., Quality of life in patients with Parkinson's disease. Park. Relat. Disord. 11 (2005), 221–226.
27. [27] Armstrong, M.J., Naglie, G., Duff-Canning, S., Meaney, C., Gill, D., Eslinger, P.J., Zadikoff, C., Mapstone, M., Chou, K.L., Persad, C., Litvan, I., Mast, B.T., Fox, S., Tang-Wai, D.F., Marras, C., Roles of education and IQ in cognitive reserve in Parkinson's disease-mild cognitive impairment. Dement. Geriatr. Cogn. Dis. Extra 2 (2012), 343–352.
28. [28] Martinez-Martin, P., Jeukens-Visser, M., Lyons, K.E., Rodriguez-Blazquez, C., Selai, C., Siderowf, A., Welsh, M., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G.T., Goetz, C.G., Schrag, A., Health-related quality-of-life scales in Parkinson's disease: critique and recommendations. Mov. Disord. 26 (2011), 2371–2380.
29. [29] Mamikonyan, E., Xie, S.X., Melvin, E., Weintraub, D., Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study. Mov. Disord. 30 (2015), 912–918.
30. [30] Cerasa, A., Gioia, M., Salsone, M., Donzuso, G., Chiriaco, C., Realmuto, S., Nicoletti, A., Bellavia, G., Banco, A., D'amelio, M., Zappia, M., Quattrone, A., Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study. Neurol. Sci. 35 (2014), 1173–1180.